General Information of the Molecule (ID: Mol02075)
Name
NADH dehydrogenase [ubiquinone] flavoprotein 1 (TbAT1) ,Trypanosoma brucei
Synonyms
Tb927.5.450b
    Click to Show/Hide
Molecule Type
Protein
Gene Name
TbAT1
Sequence
MLRRVGFLSATGSLLQAAASQQPPTQQEQRVHGGLKDQDRIFVNLYQDFGTDIDSAERRG
DWYRTRDLLLKGHDWVINEIKASGLRGRGGAGFPSGLKWSFMPKSKPDGRPSYIVVNGDE
SEPGTCKDREIMRHEPHKLVEGALIAGFAMRARYGYIYIRGEFYNEWRAVDQAIKEAYAR
GYLGRNACGSGYDFDLYTYCGAGAYICGEETAMISSIEGGPGKPRLKPPFPANVGLYGCP
TTVTNVETVSVSPTILRRGPSWFNSFGRRNNAGVKLFCICGHVNRPCTVEEEMSIPLRDL
IERHAGGVRGGWDNLLAVIPGGSSCPLIPKSICDNVLMDFDALKEAQTGLGTAAVIVMDK
STDLIAAIHRLSMFYAHESCGQCTPCREGSPWLEKMMQRFVHGNARMEEVGTMLDVSKQL
EGRTICALATAAAWPVQGLARHFTPLLQERIEKYWEANPHWGKSGSPWRRWKTHRYYAMQ
KGEKLNWDGKIVRNWN
    Click to Show/Hide
Function
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. Essential for the catalytic activity and assembly of complex I.
    Click to Show/Hide
Uniprot ID
B2ZWD5_TRYB2
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Euglenozoa
Class: Kinetoplastea
Order: Trypanosomatida
Family: Trypanosomatidae
Genus: Trypanosoma
Species: Trypanosoma brucei
Type(s) of Resistant Mechanism of This Molecule
  UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Pentamidine
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: African trypanosomiasis [1]
Resistant Disease African trypanosomiasis [ICD-11: 1F51.0]
Resistant Drug Pentamidine
Molecule Alteration Expression
Down-regulation
Experimental Note Discovered Using In-vivo Testing Model
In Vitro Model Trypanosoma brucei strain 5691
Mechanism Description Reduced uptake and cross-resistance were apparently explained by the findings that melamine-based arsenicals and diamidines are imported into trypanosomes by the same transporter, and that this transporter is defective in drug-resistant cells. The transporter was called P2 (purine transporter 2) as its physiological substrates are adenine and adenosine, both of which compete with melarsoprol for uptake and can protect trypanosomes from melarsoprol-induced lysis.
Investigative Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Melamine-based arsenicals
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: African trypanosomiasis [1]
Resistant Disease African trypanosomiasis [ICD-11: 1F51.0]
Resistant Drug Melamine-based arsenicals
Molecule Alteration Expression
Down-regulation
Experimental Note Discovered Using In-vivo Testing Model
In Vitro Model Trypanosoma brucei strain 5691
Mechanism Description Reduced uptake and cross-resistance were apparently explained by the findings that melamine-based arsenicals and diamidines are imported into trypanosomes by the same transporter, and that this transporter is defective in drug-resistant cells. The transporter was called P2 (purine transporter 2) as its physiological substrates are adenine and adenosine, both of which compete with melarsoprol for uptake and can protect trypanosomes from melarsoprol-induced lysis.
References
Ref 1 Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story .Trends Parasitol. 2013 Mar;29(3):110-8. doi: 10.1016/j.pt.2012.12.005. Epub 2013 Jan 30. 10.1016/j.pt.2012.12.005

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.